Analysis for steroid production of a Sertoli-Leydig cell tumor. 1994

R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
Union Memorial Hospital, Department of Gynecology and Obstetrics, Baltimore, Maryland 21218.

Sex cord stromal tumors of the ovary can be characterized by the production of virilizing steroid hormones. The authors present a case of a poorly differentiated Sertoli-Leydig cell tumor in which ascitic fluid was found to have a high concentration of androgenic hormones and precursors from the delta steroid pathway (17-OH progesterone, testosterone, and androstenedione). These values correlated with samples taken from the right ovarian vein, draining the ovarian neoplasm, but not with those taken from the left ovarian vein or the peripheral blood sample. Selective peritoneal fluid sampling may aid in the diagnosis of hormonally active tumors.

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids
D013256 Steroids A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed) Steroid,Catatoxic Steroids,Steroids, Catatoxic
D014770 Virilism Development of male secondary SEX CHARACTERISTICS in the FEMALE. It is due to the effects of androgenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs. Androgenization,Virilization
D018310 Sertoli-Leydig Cell Tumor A sex cord-gonadal stromal tumor consists of LEYDIG CELLS; SERTOLI CELLS; and FIBROBLASTS in varying proportions and degree of differentiation. Most such tumors produce ANDROGENS in the Leydig cells, formerly known as androblastoma or arrhenoblastoma. Androblastomas occur in the TESTIS or the OVARY causing precocious masculinization in the males, and defeminization, or virilization (VIRILISM) in the females. In some cases, the Sertoli cells produce ESTROGENS. Androblastoma,Arrhenoblastoma,Sertoli-Leydig Cell Tumors,Androblastomas,Arrhenoblastomas,Cell Tumor, Sertoli-Leydig,Cell Tumors, Sertoli-Leydig,Sertoli Leydig Cell Tumor,Sertoli Leydig Cell Tumors,Tumor, Sertoli-Leydig Cell,Tumors, Sertoli-Leydig Cell

Related Publications

R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
January 1995, Journal of the Society for Gynecologic Investigation,
R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
January 2001, Archives of gynecology and obstetrics,
R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
December 2023, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
January 1988, Journal of endocrinological investigation,
R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
December 1976, Laboratory animal science,
R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
January 1986, Archives of pathology & laboratory medicine,
R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
January 1984, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
May 1987, Nihon Sanka Fujinka Gakkai zasshi,
R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
May 2004, Journal of the Formosan Medical Association = Taiwan yi zhi,
R Sainz de la Cuesta, and J A Rock, and R Homsi, and D A Symonds, and I R Horowitz
March 2006, La Tunisie medicale,
Copied contents to your clipboard!